Request for Covid-19 Impact Assessment of this Report
The United States TB Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global TB Vaccines market, reaching US$ million by the year 2028. As for the Europe TB Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main TB Vaccines players cover Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, and China National Biotec Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of TB Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Immunotherapeutic Vaccines
Booster Vaccines
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Private Clinics
Research Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global TB Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for TB Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for TB Vaccines by Country/Region, 2017, 2022 & 2028
2.2 TB Vaccines Segment by Type
2.2.1 Immunotherapeutic Vaccines
2.2.2 Booster Vaccines
2.2.3 Others
2.3 TB Vaccines Sales by Type
2.3.1 Global TB Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global TB Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global TB Vaccines Sale Price by Type (2017-2022)
2.4 TB Vaccines Segment by Application
2.4.1 Hospitals
2.4.2 Private Clinics
2.4.3 Research Institutes
2.5 TB Vaccines Sales by Application
2.5.1 Global TB Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global TB Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global TB Vaccines Sale Price by Application (2017-2022)
3 Global TB Vaccines by Company
3.1 Global TB Vaccines Breakdown Data by Company
3.1.1 Global TB Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global TB Vaccines Sales Market Share by Company (2020-2022)
3.2 Global TB Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global TB Vaccines Revenue by Company (2020-2022)
3.2.2 Global TB Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global TB Vaccines Sale Price by Company
3.4 Key Manufacturers TB Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TB Vaccines Product Location Distribution
3.4.2 Players TB Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for TB Vaccines by Geographic Region
4.1 World Historic TB Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global TB Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global TB Vaccines Annual Revenue by Geographic Region
4.2 World Historic TB Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global TB Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global TB Vaccines Annual Revenue by Country/Region
4.3 Americas TB Vaccines Sales Growth
4.4 APAC TB Vaccines Sales Growth
4.5 Europe TB Vaccines Sales Growth
4.6 Middle East & Africa TB Vaccines Sales Growth
5 Americas
5.1 Americas TB Vaccines Sales by Country
5.1.1 Americas TB Vaccines Sales by Country (2017-2022)
5.1.2 Americas TB Vaccines Revenue by Country (2017-2022)
5.2 Americas TB Vaccines Sales by Type
5.3 Americas TB Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TB Vaccines Sales by Region
6.1.1 APAC TB Vaccines Sales by Region (2017-2022)
6.1.2 APAC TB Vaccines Revenue by Region (2017-2022)
6.2 APAC TB Vaccines Sales by Type
6.3 APAC TB Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe TB Vaccines by Country
7.1.1 Europe TB Vaccines Sales by Country (2017-2022)
7.1.2 Europe TB Vaccines Revenue by Country (2017-2022)
7.2 Europe TB Vaccines Sales by Type
7.3 Europe TB Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa TB Vaccines by Country
8.1.1 Middle East & Africa TB Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa TB Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa TB Vaccines Sales by Type
8.3 Middle East & Africa TB Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TB Vaccines
10.3 Manufacturing Process Analysis of TB Vaccines
10.4 Industry Chain Structure of TB Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TB Vaccines Distributors
11.3 TB Vaccines Customer
12 World Forecast Review for TB Vaccines by Geographic Region
12.1 Global TB Vaccines Market Size Forecast by Region
12.1.1 Global TB Vaccines Forecast by Region (2023-2028)
12.1.2 Global TB Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TB Vaccines Forecast by Type
12.7 Global TB Vaccines Forecast by Application
13 Key Players Analysis
13.1 Merck & Co.,Inc
13.1.1 Merck & Co.,Inc Company Information
13.1.2 Merck & Co.,Inc TB Vaccines Product Offered
13.1.3 Merck & Co.,Inc TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck & Co.,Inc Main Business Overview
13.1.5 Merck & Co.,Inc Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur TB Vaccines Product Offered
13.2.3 Sanofi Pasteur TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Japan BCG Laboratory
13.3.1 Japan BCG Laboratory Company Information
13.3.2 Japan BCG Laboratory TB Vaccines Product Offered
13.3.3 Japan BCG Laboratory TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Japan BCG Laboratory Main Business Overview
13.3.5 Japan BCG Laboratory Latest Developments
13.4 China National Biotec Group
13.4.1 China National Biotec Group Company Information
13.4.2 China National Biotec Group TB Vaccines Product Offered
13.4.3 China National Biotec Group TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 China National Biotec Group Main Business Overview
13.4.5 China National Biotec Group Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute TB Vaccines Product Offered
13.5.3 Serum Institute TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 India Pvt. Ltd
13.6.1 India Pvt. Ltd Company Information
13.6.2 India Pvt. Ltd TB Vaccines Product Offered
13.6.3 India Pvt. Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 India Pvt. Ltd Main Business Overview
13.6.5 India Pvt. Ltd Latest Developments
13.7 InterVax Ltd
13.7.1 InterVax Ltd Company Information
13.7.2 InterVax Ltd TB Vaccines Product Offered
13.7.3 InterVax Ltd TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 InterVax Ltd Main Business Overview
13.7.5 InterVax Ltd Latest Developments
13.8 GreenSignal
13.8.1 GreenSignal Company Information
13.8.2 GreenSignal TB Vaccines Product Offered
13.8.3 GreenSignal TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GreenSignal Main Business Overview
13.8.5 GreenSignal Latest Developments
13.9 Bio Pharma Limited
13.9.1 Bio Pharma Limited Company Information
13.9.2 Bio Pharma Limited TB Vaccines Product Offered
13.9.3 Bio Pharma Limited TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bio Pharma Limited Main Business Overview
13.9.5 Bio Pharma Limited Latest Developments
13.10 Statens Serum Institut
13.10.1 Statens Serum Institut Company Information
13.10.2 Statens Serum Institut TB Vaccines Product Offered
13.10.3 Statens Serum Institut TB Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Statens Serum Institut Main Business Overview
13.10.5 Statens Serum Institut Latest Developments
14 Research Findings and Conclusion
Table 1. TB Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. TB Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Immunotherapeutic Vaccines
Table 4. Major Players of Booster Vaccines
Table 5. Major Players of Others
Table 6. Global TB Vaccines Sales by Type (2017-2022) & (K Units)
Table 7. Global TB Vaccines Sales Market Share by Type (2017-2022)
Table 8. Global TB Vaccines Revenue by Type (2017-2022) & ($ million)
Table 9. Global TB Vaccines Revenue Market Share by Type (2017-2022)
Table 10. Global TB Vaccines Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global TB Vaccines Sales by Application (2017-2022) & (K Units)
Table 12. Global TB Vaccines Sales Market Share by Application (2017-2022)
Table 13. Global TB Vaccines Revenue by Application (2017-2022)
Table 14. Global TB Vaccines Revenue Market Share by Application (2017-2022)
Table 15. Global TB Vaccines Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global TB Vaccines Sales by Company (2020-2022) & (K Units)
Table 17. Global TB Vaccines Sales Market Share by Company (2020-2022)
Table 18. Global TB Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 19. Global TB Vaccines Revenue Market Share by Company (2020-2022)
Table 20. Global TB Vaccines Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers TB Vaccines Producing Area Distribution and Sales Area
Table 22. Players TB Vaccines Products Offered
Table 23. TB Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global TB Vaccines Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global TB Vaccines Sales Market Share Geographic Region (2017-2022)
Table 28. Global TB Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global TB Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global TB Vaccines Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global TB Vaccines Sales Market Share by Country/Region (2017-2022)
Table 32. Global TB Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global TB Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas TB Vaccines Sales by Country (2017-2022) & (K Units)
Table 35. Americas TB Vaccines Sales Market Share by Country (2017-2022)
Table 36. Americas TB Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas TB Vaccines Revenue Market Share by Country (2017-2022)
Table 38. Americas TB Vaccines Sales by Type (2017-2022) & (K Units)
Table 39. Americas TB Vaccines Sales Market Share by Type (2017-2022)
Table 40. Americas TB Vaccines Sales by Application (2017-2022) & (K Units)
Table 41. Americas TB Vaccines Sales Market Share by Application (2017-2022)
Table 42. APAC TB Vaccines Sales by Region (2017-2022) & (K Units)
Table 43. APAC TB Vaccines Sales Market Share by Region (2017-2022)
Table 44. APAC TB Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC TB Vaccines Revenue Market Share by Region (2017-2022)
Table 46. APAC TB Vaccines Sales by Type (2017-2022) & (K Units)
Table 47. APAC TB Vaccines Sales Market Share by Type (2017-2022)
Table 48. APAC TB Vaccines Sales by Application (2017-2022) & (K Units)
Table 49. APAC TB Vaccines Sales Market Share by Application (2017-2022)
Table 50. Europe TB Vaccines Sales by Country (2017-2022) & (K Units)
Table 51. Europe TB Vaccines Sales Market Share by Country (2017-2022)
Table 52. Europe TB Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe TB Vaccines Revenue Market Share by Country (2017-2022)
Table 54. Europe TB Vaccines Sales by Type (2017-2022) & (K Units)
Table 55. Europe TB Vaccines Sales Market Share by Type (2017-2022)
Table 56. Europe TB Vaccines Sales by Application (2017-2022) & (K Units)
Table 57. Europe TB Vaccines Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa TB Vaccines Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa TB Vaccines Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa TB Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa TB Vaccines Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa TB Vaccines Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa TB Vaccines Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa TB Vaccines Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa TB Vaccines Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of TB Vaccines
Table 67. Key Market Challenges & Risks of TB Vaccines
Table 68. Key Industry Trends of TB Vaccines
Table 69. TB Vaccines Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. TB Vaccines Distributors List
Table 72. TB Vaccines Customer List
Table 73. Global TB Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global TB Vaccines Sales Market Forecast by Region
Table 75. Global TB Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global TB Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas TB Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas TB Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC TB Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC TB Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe TB Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe TB Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa TB Vaccines Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa TB Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global TB Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global TB Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 87. Global TB Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global TB Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global TB Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global TB Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 91. Global TB Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global TB Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 93. Merck & Co.,Inc Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck & Co.,Inc TB Vaccines Product Offered
Table 95. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Merck & Co.,Inc Main Business
Table 97. Merck & Co.,Inc Latest Developments
Table 98. Sanofi Pasteur Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Pasteur TB Vaccines Product Offered
Table 100. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Sanofi Pasteur Main Business
Table 102. Sanofi Pasteur Latest Developments
Table 103. Japan BCG Laboratory Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Japan BCG Laboratory TB Vaccines Product Offered
Table 105. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Japan BCG Laboratory Main Business
Table 107. Japan BCG Laboratory Latest Developments
Table 108. China National Biotec Group Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. China National Biotec Group TB Vaccines Product Offered
Table 110. China National Biotec Group TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. China National Biotec Group Main Business
Table 112. China National Biotec Group Latest Developments
Table 113. Serum Institute Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute TB Vaccines Product Offered
Table 115. Serum Institute TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Serum Institute Main Business
Table 117. Serum Institute Latest Developments
Table 118. India Pvt. Ltd Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. India Pvt. Ltd TB Vaccines Product Offered
Table 120. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. India Pvt. Ltd Main Business
Table 122. India Pvt. Ltd Latest Developments
Table 123. InterVax Ltd Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. InterVax Ltd TB Vaccines Product Offered
Table 125. InterVax Ltd TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. InterVax Ltd Main Business
Table 127. InterVax Ltd Latest Developments
Table 128. GreenSignal Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. GreenSignal TB Vaccines Product Offered
Table 130. GreenSignal TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. GreenSignal Main Business
Table 132. GreenSignal Latest Developments
Table 133. Bio Pharma Limited Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Bio Pharma Limited TB Vaccines Product Offered
Table 135. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Bio Pharma Limited Main Business
Table 137. Bio Pharma Limited Latest Developments
Table 138. Statens Serum Institut Basic Information, TB Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Statens Serum Institut TB Vaccines Product Offered
Table 140. Statens Serum Institut TB Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. Statens Serum Institut Main Business
Table 142. Statens Serum Institut Latest Developments
List of Figures
Figure 1. Picture of TB Vaccines
Figure 2. TB Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TB Vaccines Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global TB Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. TB Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Immunotherapeutic Vaccines
Figure 10. Product Picture of Booster Vaccines
Figure 11. Product Picture of Others
Figure 12. Global TB Vaccines Sales Market Share by Type in 2021
Figure 13. Global TB Vaccines Revenue Market Share by Type (2017-2022)
Figure 14. TB Vaccines Consumed in Hospitals
Figure 15. Global TB Vaccines Market: Hospitals (2017-2022) & (K Units)
Figure 16. TB Vaccines Consumed in Private Clinics
Figure 17. Global TB Vaccines Market: Private Clinics (2017-2022) & (K Units)
Figure 18. TB Vaccines Consumed in Research Institutes
Figure 19. Global TB Vaccines Market: Research Institutes (2017-2022) & (K Units)
Figure 20. Global TB Vaccines Sales Market Share by Application (2017-2022)
Figure 21. Global TB Vaccines Revenue Market Share by Application in 2021
Figure 22. TB Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 23. Global TB Vaccines Revenue Market Share by Company in 2021
Figure 24. Global TB Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global TB Vaccines Revenue Market Share by Geographic Region in 2021
Figure 26. Global TB Vaccines Sales Market Share by Region (2017-2022)
Figure 27. Global TB Vaccines Revenue Market Share by Country/Region in 2021
Figure 28. Americas TB Vaccines Sales 2017-2022 (K Units)
Figure 29. Americas TB Vaccines Revenue 2017-2022 ($ Millions)
Figure 30. APAC TB Vaccines Sales 2017-2022 (K Units)
Figure 31. APAC TB Vaccines Revenue 2017-2022 ($ Millions)
Figure 32. Europe TB Vaccines Sales 2017-2022 (K Units)
Figure 33. Europe TB Vaccines Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa TB Vaccines Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa TB Vaccines Revenue 2017-2022 ($ Millions)
Figure 36. Americas TB Vaccines Sales Market Share by Country in 2021
Figure 37. Americas TB Vaccines Revenue Market Share by Country in 2021
Figure 38. United States TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC TB Vaccines Sales Market Share by Region in 2021
Figure 43. APAC TB Vaccines Revenue Market Share by Regions in 2021
Figure 44. China TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 48. India TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe TB Vaccines Sales Market Share by Country in 2021
Figure 51. Europe TB Vaccines Revenue Market Share by Country in 2021
Figure 52. Germany TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. France TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa TB Vaccines Sales Market Share by Country in 2021
Figure 58. Middle East & Africa TB Vaccines Revenue Market Share by Country in 2021
Figure 59. Egypt TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country TB Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of TB Vaccines in 2021
Figure 65. Manufacturing Process Analysis of TB Vaccines
Figure 66. Industry Chain Structure of TB Vaccines
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...